Activated Protein C to Treat Acute Lung Injuries
Public ClinicalTrials.gov record NCT00112164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Randomized Phase II Clinical Trial of Activated Protein C (Xigris) Versus Placebo for the Treatment of Acute Lung Injury
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the efficacy of activated Protein C (Xigris) for improving clinical outcomes in individuals with acute lung injury (ALI).
Study identification
- NCT ID
- NCT00112164
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Feb 2007 (Actual)
- Last update posted
- Mar 13, 2014
2005 – 2007
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Francisco at Fresno | Fresno | California | 93702 | — |
| University of Southern California | Los Angeles | California | 97239-3098 | — |
| San Francisco General Hospital | San Francisco | California | 94110 | — |
| University of California San Francisco | San Francisco | California | 94143-0130 | — |
| Stanford University, Department of Pulmonary and Critical Care | Stanford | California | 94305 | — |
| Yale School of Medicine, Section of Pulmonary & Critical Care Medicine | New Haven | Connecticut | 06520-8057 | — |
| Joseph M. Still Burn Center | Augusta | Georgia | 97239-3098 | — |
| Bay State Medical Center | Springfield | Massachusetts | 01199 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239-3098 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00112164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2014 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00112164 live on ClinicalTrials.gov.